Post by
biorun on Aug 25, 2022 9:22am
Three payment streams
Upfront, milestones (for aspects like new market introductions), and royalties.
The combination of all three will determine the value of the deal. The CEO cited that upfront and milestones are "significant", meaning in combination, so we need to consider that statement and how it needs to be interpreted. That is information already available.
As for the upfront payment itself, I would be happy with enough money to position the company for future profitability and no more dilution. This is a pharma company with a cosmetics investment, unlike animal health which is a pure pharmaceutical play. This is a key aspect to indefinitely fuel pipeline growth (anti-aging and animal diabetes to start), and this will factually be the foundation for future sustainable rebasing the typical bad mood trading price.
Comment by
fanculox on Aug 25, 2022 9:38am
show us how many shares you own, just to know what your true intention is here...
Comment by
Tickel1st on Aug 25, 2022 1:54pm
This post has been removed in accordance with Community Policy
Comment by
MirrorWorldMan on Aug 25, 2022 2:58pm
The selling of course will slowly continue indefinitely, eroding support levels. All the analysts and institutions in the world won't stop it if Howie doesn't choke up some numbers like a responsible leader.
Comment by
biorun on Aug 25, 2022 5:34pm
indefinite is a definitive word, implies forever which is not true. the stock price will indeed languish until material news or financials are reported. those that are willing to wait dor this will invest early. those that sit around here complaining should sell their shares to them or stfu.